Sugi Predict

Sugi Predict / Compounds / SCHEMBL30608624

SCHEMBL30608624

SCHEMBL30608624

CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ NAA50 Q9GZZ1 1/20 0.51
▸ CAPN1 P07384 4/20 0.46
▸ APLNR P35414 3/20 0.44
▸ NTSR1 P30989 2/20 0.43
▸ CXCL8 P10145 5/20 0.41
▸ PLK1 P53350 1/20 0.41
▸ CTSB P07858 1/20 0.40
▸ GRB2 P62993 1/20 0.40
▸ NMUR2 Q9GZQ4 1/20 0.39
▸ NMUR1 Q9HB89 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30608586 1.00 NAA50 (0.51) NAA50CAPN1APLNRNTSR1CXCL8
SCHEMBL30608598 0.97 NAA50 (0.49) NAA50CAPN1APLNRNTSR1CXCL8
SCHEMBL30608626 0.97 NAA50 (0.53) NAA50CAPN1APLNRNTSR1CXCL8
SCHEMBL30608575 0.97 NAA50 (0.49) NAA50CAPN1APLNRNTSR1CXCL8
SCHEMBL30608578 0.96 NAA50 (0.49) NAA50CAPN1APLNRNTSR1PLK1
SCHEMBL30608616 0.96 NAA50 (0.48) NAA50CAPN1APLNRNTSR1CXCL8
SCHEMBL30608580 0.95 CAPN1 (0.51) NAA50CAPN1APLNRNTSR1CTSB
SCHEMBL30608607 0.95 NAA50 (0.53) NAA50CAPN1APLNRNTSR1CXCL8
SCHEMBL30608619 0.95 NAA50 (0.49) NAA50CAPN1APLNRNTSR1CXCL8
SCHEMBL30608582 0.94 NAA50 (0.48) NAA50CAPN1APLNRNTSR1CXCL8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646232-A1 VARIANT LIGAND CONJUGATES FOR PAYLOAD DELIVERY Université de Genève (CH) 2025-11-12 — — EP claimed
WO-2024146707-A1 VARIANT LIGAND CONJUGATES FOR PAYLOAD DELIVERY UNIVERSITÉ DE GENÈVE (CH) 2024-07-11 — — WO claimed
EP-4646232-A1 VARIANT LIGAND CONJUGATES FOR PAYLOAD DELIVERY Université de Genève (CH) 2025-11-12 — — EP disclosed
US-20250090637-A1 METHODS OF INHIBITING CEREBRAL INFLAMMATION UNIVERSITÉ DE GENÈVE (CH) 2025-03-20 — — US disclosed
CN-112469429-B Use of CCR5 inhibitors in cancer treatment 奥立安生物技术瑞士有限责任公司 2025-02-14 — — CN disclosed
CN-112469430-B Method for inhibiting cerebral inflammation 日内瓦大学 2024-12-24 — — CN disclosed
WO-2024146707-A1 VARIANT LIGAND CONJUGATES FOR PAYLOAD DELIVERY UNIVERSITÉ DE GENÈVE (CH) 2024-07-11 — — WO disclosed
EP-3813870-B1 CCR5 INHIBITOR FOR USE IN TREATING CANCER ORION Biotechnology Switzerland Sarl (CH) 2023-11-15 — — EP disclosed
EP-3813869-B1 CCR5 INHIBITOR FOR USE IN TREATING A NEUROINFLAMMATORY DISORDER THAT INVOLVES CEREBRAL INFLAMMATION UNIV GENEVE (CH) 2023-10-18 — — EP disclosed
Send feedback